Two Sigma Investments, LP Stoke Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $41.6 Billion
  • Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 53,950 shares of STOK stock, worth $437,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,950
Previous 116,678 53.76%
Holding current value
$437,534
Previous $1.43 Million 58.48%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$10.8 - $13.92 $677,462 - $873,173
-62,728 Reduced 53.76%
53,950 $595,000
Q3 2024

Nov 14, 2024
BUY
$12.24 - $15.92 $21,701 - $28,226
1,773 Added 1.54%
116,678 $1.43 Million
Q2 2024

Aug 14, 2024
BUY
$11.03 - $17.52 $1.1 Million - $1.74 Million
99,405 Added 641.32%
114,905 $1.55 Million
Q1 2024

May 15, 2024
BUY
$4.12 - $14.17 $17,716 - $60,931
4,300 Added 38.39%
15,500 $209,000
Q4 2023

Feb 14, 2024
SELL
$3.37 - $5.4 $57,627 - $92,340
-17,100 Reduced 60.42%
11,200 $58,000
Q3 2023

Nov 14, 2023
BUY
$3.78 - $11.99 $29,484 - $93,522
7,800 Added 38.05%
28,300 $111,000
Q2 2023

Aug 14, 2023
BUY
$7.93 - $13.82 $27,755 - $48,370
3,500 Added 20.59%
20,500 $217,000
Q1 2023

May 15, 2023
SELL
$7.65 - $10.38 $36,368 - $49,346
-4,754 Reduced 21.85%
17,000 $141,000
Q4 2022

Feb 14, 2023
SELL
$7.07 - $15.69 $113,049 - $250,883
-15,990 Reduced 42.36%
21,754 $200,000
Q3 2022

Nov 14, 2022
BUY
$12.56 - $22.53 $273,066 - $489,824
21,741 Added 135.86%
37,744 $485,000
Q2 2022

Aug 15, 2022
BUY
$10.36 - $23.93 $49,323 - $113,930
4,761 Added 42.35%
16,003 $211,000
Q1 2022

May 16, 2022
SELL
$17.19 - $26.1 $193,989 - $294,538
-11,285 Reduced 50.1%
11,242 $237,000
Q4 2021

Feb 14, 2022
SELL
$18.11 - $30.72 $1.05 Million - $1.78 Million
-58,022 Reduced 72.03%
22,527 $540,000
Q3 2021

Nov 15, 2021
SELL
$23.65 - $34.44 $599,882 - $873,570
-25,365 Reduced 23.95%
80,549 $2.05 Million
Q2 2021

Aug 16, 2021
SELL
$30.53 - $41.09 $654,929 - $881,462
-21,452 Reduced 16.84%
105,914 $3.57 Million
Q1 2021

May 17, 2021
BUY
$36.08 - $69.81 $3.7 Million - $7.15 Million
102,426 Added 410.69%
127,366 $4.95 Million
Q4 2020

Feb 16, 2021
BUY
$33.62 - $61.93 $838,482 - $1.54 Million
24,940 New
24,940 $1.55 Million

Others Institutions Holding STOK

# of Institutions
136
Shares Held
57.3M
Call Options Held
5.7K
Put Options Held
24.4K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $320M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email